The Venous Center

Filter Your Results




Dr. Mark Garcia Appointed as Chief Medical Officer of Vesper Medical

March 4, 2019 -- Vesper Medical, Inc., a developer of venous stent solutions for peripheral vascular disease, announced the appointment of interventional radiologist Mark J. G…

Designing a Versatile Procedural Environment for a Rapidly Changing Interventional Field

With Barry T. Katzen, MD

February 2019—A dyad perspective on building an advanced endovascular suite.

Enrollment Complete in IDE Study for Medtronic's Abre Venous Stent

January 31, 2019 -- Medtronic recently completed enrollment of its investigational device exemption (IDE) study of the Abre venous self-expanding stent system. The study, whic…

Viant to Manufacture Venclose's RF Ablation Catheter for Venous Reflux Disease

January 30, 2019 -- Venclose Inc. and Viant announced a partnership for the manufacture of Venclose’s next-generation Venclose radiofrequency (RF) ablation catheter. The…

FDA Clears XableCath Crossing Catheters

January 30, 2019 -- XableCath, Inc. announced that its XableCath blunt and abrasion tip catheters were cleared by the FDA as peripheral crossing catheters. XableCath is commen…

Twelve-Month Data From VIRTUS Trial Presented for Boston Scientific's Vici Venous Stent

January 22, 2019 -- Boston Scientific Corporation announced 12-month data demonstrating a high rate of patent target lesions in patients treated with the company's Vici ve…

DVT: Access Decisions for Interventions


January 2019—Assessing the advantages and disadvantages of venous access options is crucial for safe and successful DVT intervention.

Vascular Coding Updates for 2019

Katharine L. Krol, MD, FSIR, FACR

January 2019—Changes to the interventional CPT codes for 2019 and how they will affect your practice.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.